Abrysvo .06 mg/.5mL
Respiratory Syncytial Virus Vaccine · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Pfizer Laboratories Div Pfizer Inc
Abrysvo is a injection, powder, lyophilized, for solution containing respiratory syncytial virus vaccine at .06 mg/.5mL, taken intramuscular. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Abrysvo
- Generic Name
- Respiratory Syncytial Virus Vaccine
- NDC Code (Product)
0069-2465- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- .06 mg/.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125769
- Marketing Start
- 07/30/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Abrysvo used for?
Abrysvo contains Respiratory Syncytial Virus Vaccine. It is a injection, powder, lyophilized, for solution taken intramuscular. Consult your doctor for specific uses.
Is Abrysvo a controlled substance?
Abrysvo is not classified as a controlled substance by the DEA.
What is the generic name for Abrysvo?
The generic name for Abrysvo is Respiratory Syncytial Virus Vaccine. There are 4 other brand versions of Respiratory Syncytial Virus Vaccine.
What is the NDC code for Abrysvo .06 mg/.5mL?
The NDC (National Drug Code) for Abrysvo .06 mg/.5mL is 0069-2465, listed by Pfizer Laboratories Div Pfizer Inc.